Logo RGB Strap Line

inTrigue
Volv's methodology for finding patients with difficult to diagnose and rare diseases

inTrigue is a new way of building computational models using machine learning to detect undiagnosed rare disease patients in population-scale databases such as electronic health records.
Volv has a number of ancillary products that together with the core predictive modelling make up the inTrigue methodology. The ancillary products and services enrich the insights and learnings derived from the core predictive modelling delivering further value to patients, healthcare providers and payers alike.

inTrigue: Be ready for truly personalised medicine

Using robust proprietary technology that learns digital biomarkers for any human disease, we focus on difficult-to-diagnose conditions, where there is significant unmet need.

With inTrigue, it is possible to transform disease management and treatment at the individual patient level. Significantly earlier patient diagnosis and more accurate targeting enables innovative medical practice.

Btn Rare Element 00 Grey

inTrigue is different

  1. It is built using novel data science, developed over the last fifteen years, that has been designed to find very rare 'events' in complex systems. It is ideally suited for finding difficult-to-diagnose patients scarcely represented in electronic medical record systems.
  2. It learns a model of the disease from published medical literature and does not rely on expert input or incorporate expert bias.
  3. It builds patient finding models that comprise over 10,000 features compared to traditional AI search-based models with 10s of features.
  4. In contrast to traditional machine learning approaches requiring 1,000s of example target disease patients to build an accurate prediction model, inTrigue does not require patients labelled with the disease to learn a patient finding model.
  5. It builds accurate, tailored algorithms for individual country’s based on unique medical data structures and clinical diagnosis procedures to the disease in that country.
  6. It is therefore capable of delivering powerful results globally
Btn Transfer 00 Grey

What inTrigue does very well

inTrigue learns robust prediction models that find undiagnosed and misdiagnosed patient cohorts for difficult to diagnose diseases with a very high accuracy.

As individual country systems and data are different, inTrigue learns the model in each country, adapting to differences in

  • clinical thinking
  • language
  • data structures
  • population variance

Unlocking how to find patients accurately in any language and in almost any available data set

Img in Trigue Benefits

What else does inTrigue deliver?

Unrivaled Accuracy

inTrigue’s current performance has an area under curve (AUC) of 97.5%. What does that mean? It means there are almost no false positives.

This accuracy enables reliable, clear insights in the following areas:

Btn Disease Insight 50 Whi

Disease Learning

inTrigue uses a new way to learn about your disease thereby driving new insights in:

- Symptom prioritisation;
- Patient journeys;
- The reasons for current misdiagnoses;
- Understanding variability in clinical decision making, for example, between different doctors and hospitals.

InTrigue prediction models improve via machine learning on new data.

Btn Cohorts 20 Grey

Patient Cohort Finding

InTrigue excels at cohort identification enabling precision case-finding. Start putting your real-world evidence to work and derive full value from your clinical trials. InTrigue identifies the patients that fit the cohort profile.

Btn Prevalence 50 Whi

Prevalence Insight

Stop guessing about prevalence. InTrigue brings evidence to support your prevalence claim, and introduces confidence into payer discussions about your treatment.
Based on analysis of electronic health records in each country and finding new undetected patients, true numbers of patients in a country are uncovered, which payers want to know.

Btn Rems 20 Grey

Risk Mitigation

Payers are focused today on correctly assessing the value and costs of individual medicines as a way of reducing their overall financial risk. Gaining agreement from payers is necessary, not only for unit pricing, but also to identify eligible treatment populations. Having accurate, evidence-based prevalence facilitates agreement on both points, and ensures that your payer customers derive the maximum value from their investment. This in turn builds trust in your medicines.

inTrigue enables World Class Market Access Planning

Use our precision and reliability to achieve your market access planning more effectively. Clinician adoption means improving clinical practice by helping physicians identify and treat the right patients. InTrigue high-performance prediction models are transformable into simpler models which, while still accurate, are readily-interpretable by non-experts.

Uptake with physicians shows that for companies focusing on rare diseases, the specialist diagnosing physicians become the medicine advocates, owing to the accuracy of the clinical toolsets that they can work with (and the identification of undiagnosed patients). This combination accelerates diagnosis and can reduce cost of sales significantly.

Patient satisfaction is increased as early diagnosis reduces patient frustration and increases quality of life.

inTrigue Impact on your rare disease business

By understanding more about your markets with empirical evidence derived from real-world data, inTrigue has a ripple of significant benefits through your organisation.

Read More

inTrigue Business Case

By finding more patients and finding them earlier and with greater accuracy, inTrigue helps more patients to be treated for longer. The greater accuracy also ensures that you remove risk of inappropriate treatment.

Read More

inTrigue Components

Volv inTrigue methodology, for difficult to diagnose and rare disease modelling. inTrigue is a completely new way to discover the patients that typically cannot be found.

Read More

Learn More about inTrigue and how we can make a difference for you
Please enter a value
Please enter a value
Please enter a value
Please enter a value
Please enter a value
Please enter a value
Please enter a value
Please enter a value
Please enter a value
Please enter a value